Wollaston calls for data access deal with pharma firms

Sarah Wollaston

Drug companies wanting access to a new NHS patient database should be forced to make their clinical study reports data available to relevant bodies in return, an influential Conservative MP has told HSJ.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here